Collaboration Agreements

2,002 Contracts & Agreements
Collaboration agreements include contracts that define joint initiatives between a company and other parties.
Browse Collaboration Agreements by Industry
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Collaboration and License Agreement, dated September 11, 2024, by and between Odyssey Therapeutics, Inc. and Terray Therapeutics, Inc
Collaboration Agreements
Odyssey Therapeutics, Inc.
Health Care Equipment & Supplies
2025
Strategic Collaboration, Option and License Agreement, dated March 29, 2024, by and between Odyssey Therapeutics, Inc. and Janssen Pharmaceutica NV
Collaboration Agreements
Odyssey Therapeutics, Inc.
Health Care Equipment & Supplies
2025
Amendment to Collaboration and License Agreement by and between Alopexx, Inc and Biotech Consortia, Inc
Collaboration Agreements
Alopexx, Inc.
Health Care Providers & Services
2025
Strategic Collaboration Term Sheet, dated as of January 5, 2025, by and between Ligado Networks LLC and AST & Sciences, LLC
Collaboration Agreements
New Providence Acquisition Corp.
Diversified Telecommunication Services
2025
Collaboration and License Agreement, dated May 2, 2024, by and between Xeris Pharmaceuticals, Inc. and the Registrant
Collaboration Agreements
Beta Bionics, Inc
2025
Collaboration and License Agreement dated November 8, 2013, between Orient Europharma Co., LTD. and NeOnc Technologies, Inc
Collaboration Agreements
NEONC TECHNOLOGIES HOLDINGS, INC.
2025
First Amendment to Option, License and Collaboration Agreement, dated December 19, 2024, by and between the Company and Gilead Sciences, Inc
Collaboration Agreements
ASSEMBLY BIOSCIENCES, INC.
Biotechnology
2024
Collaboration Agreement, dated December 2, 2024, by and between SmartKem Limited and FlexiIC
Collaboration Agreements
Parasol Investments Corp
2024
Amendment 3 to Development Collaboration Agreement
Collaboration Agreements
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
2024
Collaboration Agreement, dated November 19, 2024, by and between SmartKem Limited and AUO
Collaboration Agreements
Parasol Investments Corp
2024
Amended and Restated Research and Collaboration Agreement, dated August 9, 2024, by and between Aarvik Therapeutics, Inc. and the Registrant
Collaboration Agreements
ArriVent Biopharma, Inc.
2024
Fourth Amendment to Collaboration, License and Option Agreement, dated September 16, 2024, by and between Curis, Inc. and Aurigene Discovery Technologies Limite
Collaboration Agreements
CURIS INC
2024
Third Amendment to Collaboration, License and Option Agreement, dated June 4, 2020, by and between Curis, Inc. and Aurigene Discovery Technologies Limited
Collaboration Agreements
CURIS INC
2024
Second Amended and Restated Research, Collaboration & License Agreement, dated July 31, 2024, by and between the Registrant and the Trustees of the University of Pennsylvania
Collaboration Agreements
Passage BIO, Inc.
2024
Research, Collaboration & License Agreement, dated July 31, 2024, by and between the Registrant and Gemma Biotherapeutics, Inc
Collaboration Agreements
Passage BIO, Inc.
2024
Exclusive License and Collaboration Agreement, effective as of September 9, 2024, with Factor Bioscience Limited
Collaboration Agreements
NTN BUZZTIME INC
2024
Research Collaboration and License Agreement, dated September 28, 2024, by and between Juno Therapeutics, Inc. and the Registrant
Collaboration Agreements
Prime Medicine, Inc.
2024
Research Collaboration and License Agreement, dated September 13, 2024 between Korro Bio, Inc. and Novo Nordisk A/S
Collaboration Agreements
Frequency Therapeutics, Inc.
2024
Amendment No.4 to Collaboration and Option Agreement by and between the Registrant and Ono Pharmaceutical Co., Ltd, dated August 28, 2024
Collaboration Agreements
FATE THERAPEUTICS INC
2024
Third Amendment to the Collaboration and License Agreement, dated August 14, 2024, by and among the Registrant, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc
Collaboration Agreements
Poseida Therapeutics, Inc.
2024
Amendments to Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd., dated October 29, 2018
Collaboration Agreements
RIGEL PHARMACEUTICALS INC
2024
Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd., dated September 3, 2024
Collaboration Agreements
RIGEL PHARMACEUTICALS INC
2024
Fourth Amendment to the Collaboration and License Agreement by and between the Company and Incyte Corporation, Inc., dated July 24, 2024
Collaboration Agreements
MACROGENICS INC
2024
Amendment No. 3 entered into as of August 1, 2024 to the Master Collaboration Agreement dated as of April 8, 2019 by and between the Registrant and Regeneron Pharmaceuticals, Inc
Collaboration Agreements
ALNYLAM PHARMACEUTICALS, INC.
2024
Market Development and Collaboration Agreement
Collaboration Agreements
ADiTx Therapeutics, Inc.
2024
Collaboration and License Agreement by and between Alopexx, Inc and Biotech Consortia, Inc
Collaboration Agreements
Alopexx, Inc.
2024
Clinical Trial Collaboration and Supply Agreement, by and between the Registrant and MSD International GmbH and MSD International Business GmbH, dated May 19, 2022
Collaboration Agreements
Bicara Therapeutics Inc.
2024
Research and Collaboration Agreement Between Jiangsu Alphamab Biopharmaceuticals Co., Ltd and Arrivent Biopharma, Inc
Collaboration Agreements
ArriVent Biopharma, Inc.
2024
First Amendment to Collaboration and License Agreement, dated as of May 14, 2024, by and between the Registrant and Torii Pharmaceuticals Co., Ltd
Collaboration Agreements
Verrica Pharmaceuticals Inc.
2024
Amendment No. 4 to the Research Collaboration Agreement, dated May 2, 2024, by and between Nkarta, Inc. and CRISPR Therapeutics AG
Collaboration Agreements
Nkarta, Inc.
2024
Amendment No. 3 to the Research Collaboration Agreement, dated April 3, 2024, by and between Nkarta, Inc. and CRISPR Therapeutics AG
Collaboration Agreements
Nkarta, Inc.
2024
Amendment No. 1 to Collaboration and License Agreement by and between the Company and Everest Medicines II (HK) Limited, dated as of July 2, 2024
Collaboration Agreements
Kezar Life Sciences, Inc.
2024
Collaboration and License Agreement dated May 3, 2024 by and among GB002, Inc., Gossamer Bio 002 Ltd. and Gossamer Bio, Inc. on the one hand and CHIESI Farmaceutici S.p.A and...
Collaboration Agreements
Gossamer Bio, Inc.
2024
First Amended and Restated Collaboration Agreement, dated April 2, 2024, by and between Adimab, LLC and Leap Therapeutics, Inc
Collaboration Agreements
LEAP THERAPEUTICS, INC.
2024
Amendment to Research Collaboration and License Agreement with Giiant Pharma, Inc. dated August 2, 2024
Collaboration Agreements
Neuralstem, Inc.
2024
FNAIT Collaboration Agreement, dated April 9, 2024, by and between Momenta Pharmaceuticals, Inc. and Rallybio IPA, LLC
Collaboration Agreements
Rallybio Corp
2024
Amendment No. 4 to the Option, License and Collaboration Agreement between Arcus Biosciences, Inc. and Gilead Sciences, Inc., dated May 10, 2024
Collaboration Agreements
Arcus Biosciences, Inc.
2024
Third Amendment to Collaboration and Commercialization Agreement, by and between the Subsidiary and Ascensia Diabetes Care
Collaboration Agreements
Senseonics Holdings, Inc.
2024
Collaboration Agreement, dated May 6, 2024, between the Registrant and The Swiss Group for Cancer Research SAKK
Collaboration Agreements
INTENSITY THERAPEUTICS, INC.
2024
Amendment No.1 to the Collaboration and License Agreement effective as of June 28, 2024 by and between CytomX Therapeutics, Inc. and Regeneron Pharmaceuticals, Inc
Collaboration Agreements
CytomX Therapeutics, Inc.
2024